Back to Sumitomo Mitsui DS Asset Management Company, Ltd Sumitomo Mitsui DS Asset Management Company, Ltd

ALXNALXN
11 quarters

Position history for Sumitomo Mitsui DS Asset Management Company, LtdSumitomo Mitsui DS Asset Management Company, Ltd's holdings in ALEXION PHARMACEUTICALS INC

Sumitomo Mitsui DS Asset Management Company, Ltd previously held 0 shares of ALXN (ALEXION PHARMACEUTICALS INC), worth $0 as of 2021-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$2.1M

Total Shares Change

-15,282

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2021-Q2
Decreased
13,841
-0.8%
$2.5M0.1%
0
2021-Q1
Increased
13,948
+0.2%
$2.1M0.1%
26
2020-Q4
Decreased
13,917
-0.2%
$2.2M0.1%
0
2020-Q3
Increased
13,946
+1.6%
$1.6M0.1%
26
2020-Q2
Increased
13,724
+5.6%
$1.5M0.1%
27
2020-Q1
Decreased
12,994
-6.0%
$1.2M0.0%
0
2019-Q4
Decreased
13,816
-0.3%
$1.5M0.1%
0
2019-Q3
Increased
13,860
+16.1%
$1.4M0.1%
29
2019-Q2
Decreased
11,933
-21.9%
$1.6M0.1%
0
2019-Q1
New
15,282
-
$2.1M0.0%
36

Other major holders of ALXN: FARALLON CAPITAL MANAGEMENT, L.L.C., JENNISON ASSOCIATES LLC, BAKER BROS. ADVISORS LP, HBK INVESTMENTS L P

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used